North America Low Molecular Weight Heparin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Enoxaparin, Dalteparin, Tinzaparin, Fraxiparine, Nadroparin, and Others), Packaging (Multi-Vials and Prefilled Syringes), Application [Deep Vein Thrombosis, Acute Coronary Syndrome (ACS), Pulmonary Embolism, and Others], and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others)

Name: North America Low Molecular Weight Heparin Market
SKU: Healthcare IT
Rating: 4.9 (12 reviews)

The low molecular weight heparin market in North America is expected to grow from US$ 1,232.86 million in 2021 to US$ 1,963.46 million by 2028; it is estimated to grow at a CAGR of 6.9% from 2021 to 2028.

Anticoagulants prevent clotting of blood and the growth of existing blood clots in blood vessels. In recent years, the development of methods for the prevention, and pharmacological and surgical treatment of thrombosis have improved considerably. The LMWHs are being used in the treatment of antithrombotic diseases for the past two decades. Owing to the structural complexity of anticoagulants and the presence of impurities, their structural characterization requires advanced analytical techniques. The LMWH exhibits anticoagulant properties such as anti-tumor, anti-inflammatory, and anti-proliferative effects, which are useful in the treatment of pathologies such as nephrotic syndrome and Alzheimer's disease. The patents of LMWH's have now expired. However, the market potential for LMWH is growing due to the increasing use in several emerging countries owing to its uses, such as thromboprophylaxis, venous thromboembolism (VTE), and anticoagulation treatment during pregnancy. As a result, pharmaceutical companies in many countries are focused on producing generic LMWHs. Enoxaparin is the world's best-selling LMWH. Pharmaceutical companies are also conducting various research and development activities to manufacture enoxaparin biosimilar. This further leads to intense competition in the LMWH market. Pharmaceutical companies either produced biosimilars or renamed the generic versions of the branded LMWH. In particular, copies of enoxaparin are available mainly in North America, which is further anticipated to drive the market in North America.

North America is highly affected due to the COVID-19 pandemic. This led to increased demand for diagnosing and therapeutic devices in hospitals. The FDA has increased its efforts to provide healthcare to people and has imposed several guidelines for hospitals and medical device companies. Various companies also enhanced their research and development activities for diagnostics tests and therapeutic devices. Despite facing the ill effects of SARS and H1N1 outbreaks in the last few years, the severity of the COVID-19 pandemic made the situation more complicated for the healthcare sectors due to its mode of transmission. The ongoing pandemic is straining public health systems globally, interrupting and delaying critical healthcare procedures. As per the IRI data, demand for various dietary supplements grew after the onset of the COVID-19 pandemic in the US at unprecedented rates. The total supplement sales increased by 6% during the first week of March 2020.

North America Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :

North America Low Molecular Weight Heparin Market Segmentation

North America Low Molecular Weight Heparin Market – By Product Type

North America Low Molecular Weight Heparin Market – By Packaging

Multi-Vials
Prefilled Syringes

North America Low Molecular Weight Heparin Market – By Application

Deep Vein Thrombosis
Acute Coronary Syndrome (ACS)
Pulmonary Embolism
Others

North America Low Molecular Weight Heparin Market – By End User

Hospitals
Clinics
Ambulatory Surgical Centers
Others

North America Low Molecular Weight Heparin Market– By Country

US
Canada
Mexico

North America Low Molecular Weight Heparin Market-Companies Mentioned

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Low Molecular Weight Heparin Market – By Product Type

1.3.2 North America Low Molecular Weight Heparin Market – By Packaging

1.3.3 North America Low Molecular Weight Heparin Market – By Application

1.3.4 North America Low Molecular Weight Heparin Market – By End User

1.3.5 North America Low Molecular Weight Heparin Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Low Molecular Weight Heparin Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.3 Experts Opinion

5. North America Low Molecular Weight Heparin Market– Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Future Trends

5.4 Impact Analysis

6. Low Molecular Weight Heparin Market– North America Analysis

6.1 North America Low Molecular Weight Heparin Market Revenue Forecast and Analysis

7. North America Low Molecular Weight Heparin Market– By Product Type

7.1 Overview

7.2 North America Low Molecular Weight Heparin Market, By Product Type, 2021 & 2028 (%)

7.3 Enoxaparin

7.3.1 Overview

7.3.2 Enoxaparin: North America Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

7.4 Dalteparin

7.4.1 Overview

7.4.2 Dalteparin: North America Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

7.5 Nadroparin

7.5.1 Overview

7.5.2 Nadroparin: North America Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

7.6 Fraxiparine

7.6.1 Overview

7.6.2 Fraxiparine: North America Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

7.7 Tinzaparin

7.7.1 Overview

7.7.2 Tinzaparin: North America Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

7.8 Others

7.8.1 Overview

7.8.2 Others: North America Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

8. North America Low Molecular Weight Heparin Market– By Packaging

8.1 Overview

8.2 North America Low Molecular Weight Heparin Market Share by Packaging - 2021 & 2028 (%)

8.3 Multi-Vials

8.3.1 Overview

8.3.2 Multi-Vials: North America Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

8.4 Prefilled Syringes

8.4.1 Overview

8.4.2 Prefilled Syringes: North America Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

9. North America Low Molecular Weight Heparin Market– By Application

9.1 Overview

9.2 North America Low Molecular Weight Heparin Market, By Application, 2021 & 2028 (%)

9.3 Deep Vein Thrombosis

9.3.1 Overview

9.3.2 Deep Vein Thrombosis: North America Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

9.4 Acute Coronary Syndrome (ACS)

9.4.1 Overview

9.4.2 Acute Coronary Syndrome (ACS): North America Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

9.5 Pulmonary Embolism

9.5.1 Overview

9.5.2 Pulmonary Embolism: North America Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: North America Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

10. North America Low Molecular Weight Heparin Market– By End User

10.1 Overview

10.2 North America Low Molecular Weight Heparin Market, By End User, 2021 & 2028 (%)

10.3 Hospitals

10.3.1 Overview

10.3.2 Hospitals: North America Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

10.4 Clinics

10.4.1 Overview

10.4.2 Clinics: North America Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

10.5 Ambulatory Surgical Centers

10.5.1 Overview

10.5.2 Ambulatory Surgical Centers: North America Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

10.6 Others

10.6.1 Overview

10.6.2 Others: North America Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

11. North America Low Molecular Weight Heparin Market – Country Analysis

11.1 North America: Low Molecular Weight Heparin Market to 2028

11.1.1 Overview

11.1.2 North America: Low Molecular Weight Heparin Market, by Country, 2021 & 2028 (%)

11.1.2.1 US: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (US$ Million)

11.1.2.1.1 US: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (US$ Million)

11.1.2.1.2 US: Low Molecular Weight Heparin Market, by Product Type, 2019–2028 (US$ Million)

11.1.2.1.3 US: Low Molecular Weight Heparin Market, by Packaging, 2019–2028 (US$ Million)

11.1.2.1.4 US: Low Molecular Weight Heparin Market, by Application, 2019–2028 (US$ Million)

11.1.2.1.5 US: Low Molecular Weight Heparin Market, by End User, 2019–2028 (US$ Million)

11.1.2.2 Canada: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (US$ Million)

11.1.2.2.1 Canada: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (US$ Million)

11.1.2.2.2 Canada: Low Molecular Weight Heparin Market, by Product Type, 2019–2028 (US$ Million)

11.1.2.2.3 Canada: Low Molecular Weight Heparin Market, by Packaging, 2019–2028 (US$ Million)

11.1.2.2.4 Canada: Low Molecular Weight Heparin Market, by Application, 2019–2028 (US$ Million)

11.1.2.2.5 Canada: Low Molecular Weight Heparin Market, by End User, 2019–2028 (US$ Million)

11.1.2.3 Mexico: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (US$ Million)

11.1.2.3.1 Mexico: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (US$ Million)

11.1.2.3.2 Mexico: Low Molecular Weight Heparin Market, by Product Type, 2019–2028 (US$ Million)

11.1.2.3.3 Mexico: Low Molecular Weight Heparin Market, by Packaging, 2019–2028 (US$ Million)

11.1.2.3.4 Mexico: Low Molecular Weight Heparin Market, by Application, 2019–2028 (US$ Million)

11.1.2.3.5 Mexico: Low Molecular Weight Heparin Market, by End User, 2019–2028 (US$ Million)

12. Impact of COVID-19 Pandemic on North America Low Molecular Weight Heparin Market

12.1 North America: Impact Assessment of COVID-19 Pandemic

13. North America Low Molecular Weight Heparin Market–Industry Landscape

13.1 Overview

13.2 Organic Developments

13.2.1 Overview

13.3 Inorganic Developments

13.3.1 Overview

14. Company Profiles

14.1 TEVA PHARMACEUTICAL INDUSTRIES LTD

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Abbott

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Novartis

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Sanofi

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Pfizer Inc.

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 B. Braun Medical Inc.

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 Dr. Reddy's Laboratories

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 LEO Pharma A/S

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 Aspen Holdings

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

LIST OF TABLES

Table 1. North America Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (US$ Million)

Table 2. US Low Molecular Weight Heparin Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 3. US: Low Molecular Weight Heparin Market, by Packaging– Revenue and Forecast to 2028 (US$ Million)

Table 4. US: Low Molecular Weight Heparin Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 5. US: Low Molecular Weight Heparin Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 6. Canada: Low Molecular Weight Heparin Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 7. Canada Low Molecular Weight Heparin Market, by Packaging– Revenue and Forecast to 2028 (US$ Million)

Table 8. Canada: Low Molecular Weight Heparin Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 9. Canada: Low Molecular Weight Heparin Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 10. Mexico: Low Molecular Weight Heparin Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 11. Mexico Low Molecular Weight Heparin Market, by Packaging– Revenue and Forecast to 2028 (US$ Million)

Table 12. Mexico: Low Molecular Weight Heparin Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 13. Mexico: Low Molecular Weight Heparin Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 14. Organic Developments in the North America Low Molecular Weight Heparin Market

Table 15. Inorganic Developments in the North America Low Molecular Weight Heparin Market

Table 16. Glossary of Terms, North America Low Molecular Wight Heparin Market

LIST OF FIGURES

Figure 1. North America Low Molecular Weight Heparin Market Segmentation

Figure 2. North America Low Molecular Weight Heparin Market, By Country

Figure 3. North America Low Molecular Weight Heparin Market Overview

Figure 4. Enoxaparin Segment Held Largest Share of Product Type Segment in North America Low Molecular Weight Heparin Market

Figure 5. US is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. North America: PEST Analysis

Figure 7. Experts Opinion

Figure 8. North America Low Molecular Weight Heparin Market Impact Analysis of Driver and Restraints

Figure 9. North America Low Molecular Weight Heparin Market– Revenue Forecast and Analysis – 2020- 2028

Figure 10. North America Low Molecular Weight Heparin Market, By Product Type, 2021 & 2028 (%)

Figure 11. Enoxaparin: North America Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 12. Dalteparin: North America Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 13. Nadroparin: North America Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 14. Fraxiparine: North America Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 15. Tinzaparin: North America Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 16. Others: North America Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 17. North America LMWH Market Share by Packaging - 2021 & 2028 (%)

Figure 18. Multi-Vials: North America Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 19. Prefilled Syringes: North America Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 20. North America Low Molecular Weight Heparin Market, By Application, 2021 & 2028 (%)

Figure 21. Deep Vein Thrombosis: North America Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 22. Acute Coronary Syndrome (ACS): North America Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 23. Pulmonary Embolism: North America Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 24. Others: North America Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 25. North America Low Molecular Weight Heparin Market, By End User, 2021 & 2028 (%)

Figure 26. Hospitals: North America Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 27. Clinics: North America Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 28. Ambulatory Surgical Centers: North America Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 29. Others: North America Low Molecular Weight Heparin Market Revenue and Forecast to 2028 (US$ Million)

Figure 30. North America: Low Molecular Weight Heparin Market, by Key Country – Revenue (2021) (US$ Million)

Figure 31. North America: Low Molecular Weight Heparin Market, by Country, 2021 & 2028 (%)

Figure 32. US: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33. Canada: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34. Mexico: Low Molecular Weight Heparin Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35. Impact of COVID-19 Pandemic in North American Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America Low Molecular Weight Heparin Market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America Low Molecular Weight Heparin Market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the Low Molecular Weight Heparin Market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele..	May 2022
North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000